Fig. 3From: Do anti-malarials in Africa meet quality standards? The market penetration of non quality-assured artemisinin combination therapy in eight African countriesAvailability of QAACT and non-QAACT in the public sector. Significant difference in non-QAACT availability between first and final survey year: *p < 0.05, **p < 0.01, ***p < 0.001Back to article page